Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
Stefano Federico, Luca Pozzetti, Alessandro Papa, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13466-13513
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19
Hassan A. Alhazmi, Asim Najmi, Sadique A. Javed, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 105
Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications
Yi-Hsin Chen, Kang‐Hsi Wu, Han‐Ping Wu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5037-5037
Open Access | Times Cited: 15
The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management
Kiarash Saleki, Parsa Alijanizadeh, Nima Javanmehr, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 3, pp. 1267-1325
Open Access | Times Cited: 13
The Current Status of Latency Reversing Agents for HIV-1 Remission
Anthony Rodari, Gilles Darcis, Carine Van Lint
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 491-514
Open Access | Times Cited: 92
The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?
Bahareh Kashani, Zahra Zandi, Atieh Pourbagheri‐Sigaroodi, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 6, pp. 4121-4137
Closed Access | Times Cited: 75
Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
Saghar Pahlavanneshan, Ali Sayadmanesh, Hamidreza Ebrahimiyan, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 72
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
F. Navarro Expósito, Miriam Redrado, Maeva Houry, et al.
Cancer Research (2023) Vol. 83, Iss. 15, pp. 2513-2526
Open Access | Times Cited: 22
Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death
Asmita Banstola, Kishwor Poudel, Jong Oh Kim, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 505-520
Closed Access | Times Cited: 51
Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system
Z. Zhao, Chen Hou, Naihong Yan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
Lingling Huang, Xiaoyan Ge, Yang Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1228-1228
Open Access | Times Cited: 32
Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics
Jiayu Wang, Jifa Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6437-6462
Closed Access | Times Cited: 18
Genetically engineered cell membrane-coated nanoparticles for antibacterial and immunoregulatory dual-function treatment of ligature-induced periodontitis
Yangjia Deng, Mingxing Ren, Ping He, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 17
Hyaluronic acid-silybin conjugate for the preparation of multifunctional, biomimetic, vancomycin-loaded self-assembled polymersomes against bacterial sepsis
Mohammed A. Gafar, Calvin A. Omolo, Usri H. Ibrahim, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140152-140152
Closed Access
Antimicrobial peptide-fucoidan nanoplexes: A novel multifunctional biomimetic nanocarrier for enhanced vancomycin delivery against bacterial infections and sepsis
Mohammed A. Gafar, Calvin A. Omolo, Usri H. Ibrahim, et al.
International Journal of Pharmaceutics (2025), pp. 125344-125344
Closed Access
TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects
Arshpreet Kaur, Deepender Kaushik, Sakshi Piplani, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 233-278
Closed Access | Times Cited: 40
Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors
Arindam Talukdar, Dipyaman Ganguly, Swarnali Roy, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8010-8041
Closed Access | Times Cited: 35
Molecular mechanism underlying the TLR4 antagonistic and antiseptic activities of papiliocin, an insect innate immune response molecule
Manigandan Krishnan, Joonhyeok Choi, Ahjin Jang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 10
Open Access | Times Cited: 25
The scientific journey of a novel adjuvant (AS37) from bench to bedside
Ugo D’Oro, Derek T. O’Hagan
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Revolutionizing Cancer Therapy using Tetrahedral DNA Nanostructures as Intelligent Drug Delivery Systems
Ayushi Sharma, Payal Vaswani, Dhiraj Bhatia
Nanoscale Advances (2024) Vol. 6, Iss. 15, pp. 3714-3732
Open Access | Times Cited: 4
Epigenetic modulation of immune cells: Mechanisms and implications
Stefano Fiordoro, Camillo Rosano, Eugenia Pechkova, et al.
Advances in Biological Regulation (2024) Vol. 94, pp. 101043-101043
Closed Access | Times Cited: 4
Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles
Deepender Kaushik, Arshpreet Kaur, Nikolai Petrovsky, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 7, pp. 1065-1120
Open Access | Times Cited: 28
Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
Jun Liu, Hui Zhang, Yanhong Su, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy
Xiaohong Cen, Baoqu Wang, Yuqing Liang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3667-3681
Open Access | Times Cited: 18
Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
Run Zheng, Jian Ma
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2285-2285
Open Access | Times Cited: 18
The effects of the combination therapy of chemotherapy drugs on the fluctuations of genes involved in the TLR signaling pathway in glioblastoma multiforme therapy
Seyedeh Elham Norollahi, Shahrokh Yousefzadeh-Chabok, Bahman Yousefi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117137-117137
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top